Bausch Health Companies | Fremdkapital



Loan Capital Veränderung Datum
Amgen USD 53.76B 253M 2025-06
ANI Pharmaceuticals USD 608.35M 3.28M 2025-06
Aurora Cannabis CAD 36.3M 3.89M 2025-06
Bausch Health Companies USD 20.86B 369M 2025-06
Biogen USD 6.28B 1.74B 2025-06
Bristol-Myers Squibb USD 44.47B 1.69B 2025-06
Canopy Growth CAD 289M 178.93M 2025-06
Corcept Therapeutics USD 0 0 2025-03
Danaher USD 16.85B 877M 2025-06
Drreddys Laboratories INR 59.47M 3.74B 2025-06
Eli Lilly USD 34.18B 319.4M 2025-06
Gilead Sciences USD 22.14B 6M 2025-06
Novo Nordisk 87.3B 9.01B 2025-06
Pacira USD 378.1M 3.2M 2025-06
Perrigo USD 3.62B 24.2M 2025-06
Prestige Brands USD 1.01B 256K 2025-06
Supernus Pharmaceuticals USD 0 0 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12
Zoetis USD 5.23B 4M 2025-06


Bausch Health Companies Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2025.